Dual Trigger Versus Booster Dose of HCG

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02397642
• Date of registration: 16/03/2015
• Prospective Registration: No
• Primary sponsor: Cairo University
• Public title: Dual Trigger Versus Booster Dose of HCG
• Scientific title: Dual Trigger Versus Booster Dose of HCG on Ovum Pickup Day in Antagonist IVF/ICSI Cycles Triggered With GnRH Agonist in High Responder Females to Salvage the Luteal Phase
• Date of first enrolment: March 2015
• Target sample size: 200
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02397642
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Egypt

Contacts

• Name: Sarwat Ahwany, MD
• Affiliation: Cairo University

Key inclusion & exclusion criteria

Inclusion Criteria:

- High responder females undergoing antagonist protocol IVF/ICSI cycle

- More than 14 MII oocytes

- Estradiol more than 3500 pg/ml on day of trigger

Exclusion Criteria:

- Any other protocol

- Normal or poor responders



Age minimum: 20 Years
Age maximum: 37 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Infertility

Intervention(s)

Drug: Human Chorionic Gonadotropin

Procedure: IVF/ICSI

Primary Outcome(s)

Clinical pregnancy rate [Time Frame: 1 year]

Secondary Outcome(s)

OHSS rate [Time Frame: 1 year]

Secondary ID(s)

12015

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Nile Ivf Center, Cairo, Egypt

Adam International Hospital